Heterogeneous intrastriatal pattern of proteins regulating axon growth in normal adult human brain

Neurobiology of Disease

Volumn 41, Issue 2, 2011, Pages 458-468

  Tong, Junchao ^a   Furukawa, Yoshiaki ^a,b   Sherwin, Allan ^c   Hornykiewicz, Oleh ^d   Kish, Stephen J ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c MCGILL UNIVERSITY   (Canada)

^d Medical University of Vienna   (Austria)

Author keywords

Aging; Axon growth; Bcl 2; Doublecortin; Glial fibrillary acidic protein; Human leukocyte antigen; Parkinson's disease; PSA NCAM; Striatum; TUC 4

Indexed keywords

ALPHA TUBULIN; BIM PROTEIN; CD45 ANTIGEN; DOPAMINE; DOUBLECORTIN; ENOLASE; GLIAL FIBRILLARY ACIDIC PROTEIN; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; MICROTUBULE ASSOCIATED PROTEIN 4; NERVE CELL ADHESION MOLECULE; PROTEIN BAD; PROTEIN BAK; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BID;

ADULT; AGED; AGING; ANTIBODY SPECIFICITY; ARTICLE; AUTOPSY; CAUDATE NUCLEUS; CELL HETEROGENEITY; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MALE; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PUTAMEN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CELL AGING; CORPUS STRIATUM; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; GROWTH CONES; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MUSCLE PROTEINS; NERVE GROWTH FACTORS; NEURONAL PLASTICITY; NEUROPEPTIDES; PROTO-ONCOGENE PROTEINS C-BCL-2; YOUNG ADULT;

EID: 78650601626     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2010.10.017     Document Type: Article

References (81)

1. Abe O., Yamasue H., Aoki S., Suga M., Yamada H., Kasai K., et al. Aging in the CNS: comparison of gray/white matter volume and diffusion tensor data. Neurobiol. Aging 2008, 29:102-116.
2. Adams J.M., Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998, 281:1322-1326.
3. Adams T.E., Bodmer J.G., Bodmer W.F. Production and characterization of monoclonal antibodies recognizing the alpha-chain subunits of human is alloantigens. Immunology 1983, 50:613-624.
4. Alabed Y.Z., Pool M., Ong Tone S., Sutherland C., Fournier A.E. GSK3 beta regulates myelin-dependent axon outgrowth inhibition through CRMP4. J. Neurosci. 2010, 30:5635-5643.
5. Appel S.H. A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer disease. Ann. Neurol. 1981, 10:499-505.
6. Benjamini Y., Drai D., Elmer G., Kafkafi N., Golani I. Controlling the false discovery rate in behavior genetics research. Behav. Brain Res. 2001, 125:279-284.
7. Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J. Neurol. Sci. 1973, 20:415-455.
8. Bernier P.J., Parent A. Bcl-2 protein as a marker of neuronal immaturity in postnatal primate brain. J. Neurosci. 1998, 18:2486-2497.
9. Blackmore M.G., Moore D.L., Smith R.P., Goldberg J.L., Bixby J.L., Lemmon V.P. High content screening of cortical neurons identifies novel regulators of axon growth. Mol. Cell. Neurosci. 2010, 44:43-54.
10. Bonfanti L., Olive S., Poulain D.A., Theodosis D.T. Mapping of the distribution of polysialylated neural cell adhesion molecule throughout the central nervous system of the adult rat: an immunohistochemical study. Neuroscience 1992, 49:419-436.
11. Chan C.S., Guzman J.N., Ilijic E., Mercer J.N., Rick C., Tkatch T., et al. 'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature 2007, 447:1081-1086.
12. Chen D.F., Schneider G.E., Martinou J.C., Tonegawa S. Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature 1997, 385:434-439.
13. Cheng H.C., Ulane C.M., Burke R.E. Clinical progression in Parkinson disease and the neurobiology of axons. Ann. Neurol. 2010, 67:715-725.
14. Dahl D., Bignami A. Glial fibrillary acidic protein from normal and gliosed human brain. Demonstration of multiple related polypeptides. Biochim. Biophys. Acta 1975, 386:41-51.
15. Damier P., Hirsch E.C., Agid Y., Graybiel A.M. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 1999, 122(Pt 8):1437-1448.
16. David J.P., Ghozali F., Fallet-Bianco C., Wattez A., Delaine S., Boniface B., et al. Glial reaction in the hippocampal formation is highly correlated with aging in human brain. Neurosci. Lett. 1997, 235:53-56.
17. Di Giovanni S. Molecular targets for axon regeneration: focus on the intrinsic pathways. Expert Opin. Ther. Targets 2009, 13:1387-1398.
18. Ehringer H., Hornykiewicz O. Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system. Klin. Wochenschr. 1960, 38:1236-1239.
19. El Maarouf A., Petridis A.K., Rutishauser U. Use of polysialic acid in repair of the central nervous system. Proc. Natl Acad. Sci. USA 2006, 103:16989-16994.
20. Fahrner A., Kann G., Flubacher A., Heinrich C., Freiman T.M., Zentner J., et al. Granule cell dispersion is not accompanied by enhanced neurogenesis in temporal lobe epilepsy patients. Exp. Neurol. 2007, 203:320-332.
21. Finn O.J., Levy R. Multiple HLA-DR antigens: detection with monoclonal antibodies and translation in vitro. Proc. Natl Acad. Sci. USA 1982, 79:2658-2662.
22. Fjell A.M., Westlye L.T., Amlien I., Espeseth T., Reinvang I., Raz N., et al. High consistency of regional cortical thinning in aging across multiple samples. Cereb. Cortex 2009, 19:2001-2012.
23. Fjell A.M., Westlye L.T., Amlien I., Espeseth T., Reinvang I., Raz N., et al. Minute effects of sex on the aging brain: a multisample magnetic resonance imaging study of healthy aging and Alzheimer's disease. J. Neurosci. 2009, 29:8774-8783.
24. Francis F., Koulakoff A., Boucher D., Chafey P., Schaar B., Vinet M.C., et al. Doublecortin is a developmentally regulated, microtubule-associated protein expressed in migrating and differentiating neurons. Neuron 1999, 23:247-256.
25. Franz C.K., Rutishauser U., Rafuse V.F. Intrinsic neuronal properties control selective targeting of regenerating motoneurons. Brain 2008, 131:1492-1505.
26. Gibb W.R. Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease. Brain Res. 1992, 581:283-291.
27. Gibb W.R., Lees A.J. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 1991, 54:388-396.
28. Gleeson J.G., Lin P.T., Flanagan L.A., Walsh C.A. Doublecortin is a microtubule-associated protein and is expressed widely by migrating neurons. Neuron 1999, 23:257-271.
29. Gonzalez-Hernandez T., Barroso-Chinea P., De La Cruz Muros I., Del Mar Perez-Delgado M., Rodriguez M. Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons. J. Comp. Neurol. 2004, 479:198-215.
30. Graeber M.B., Bise K., Mehraein P. CR3/43, a marker for activated human microglia: application to diagnostic neuropathology. Neuropathol. Appl. Neurobiol. 1994, 20:406-408.
31. Greenberg D.L., Messer D.F., Payne M.E., Macfall J.R., Provenzale J.M., Steffens D.C., et al. Aging, gender, and the elderly adult brain: an examination of analytical strategies. Neurobiol. Aging 2008, 29:290-302.
32. Hirsch E.C., Hunot S. Neuroinflammation in Parkinson's disease: a target for neuroprotection?. Lancet Neurol. 2009, 8:382-397.
33. Hirsch E., Graybiel A.M., Agid Y.A. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 1988, 334:345-348.
34. Hornykiewicz O. Biochemical aspects of Parkinson's disease. Neurology 1998, 51:S2-S9.
35. Jarskog L.F., Gilmore J.H. Developmental expression of Bcl-2 protein in human cortex. Brain Res. Dev. Brain Res. 2000, 119:225-230.
36. Kastner A., Hirsch E.C., Lejeune O., Javoy-Agid F., Rascol O., Agid Y. Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?. J. Neurochem. 1992, 59:1080-1089.
37. Kish S.J., Shannak K., Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J. Med. 1988, 318:876-880.
38. Kish S.J., Robitaille Y., el-Awar M., Clark B., Schut L., Ball M.J., et al. Striatal monoamine neurotransmitters and metabolites in dominantly inherited olivopontocerebellar atrophy. Neurology 1992, 42:1573-1577.
39. Kish S.J., Fitzmaurice P.S., Boileau I., Schmunk G.A., Ang L.C., Furukawa Y., et al. Brain serotonin transporter in human methamphetamine users. Psychopharmacology (Berl.) 2009, 202:649-661.
40. Knoth R., Singec I., Ditter M., Pantazis G., Capetian P., Meyer R.P., et al. Murine features of neurogenesis in the human hippocampus across the lifespan from 0 to 100years. PLoS ONE 2010, 5:e8809.
41. Krajewski S., Krajewska M., Shabaik A., Wang H.G., Irie S., Fong L., et al. Immunohistochemical analysis of in vivo patterns of Bcl-X expression. Cancer Res. 1994, 54:5501-5507.
42. Lach B., Grimes D., Benoit B., Minkiewicz-Janda A. Caudate nucleus pathology in Parkinson's disease: ultrastructural and biochemical findings in biopsy material. Acta Neuropathol. 1992, 83:352-360.
43. Lee J., Zhu W.M., Stanic D., Finkelstein D.I., Horne M.H., Henderson J., et al. Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia. Brain 2008, 131:1574-1587.
44. Levy O.A., Malagelada C., Greene L.A. Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps. Apoptosis 2009, 14:478-500.
45. Liberatore G.T., Finkelstein D.I., Wong J.Y., Horne M.K., Porritt M.J., Donnan G.A., et al. Sprouting of dopaminergic axons after striatal injury: confirmation by markers not dependent on dopamine metabolism. Exp. Neurol. 1999, 159:565-573.
46. Love S., Plaha P., Patel N.K., Hotton G.R., Brooks D.J., Gill S.S. Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain. Nat. Med. 2005, 11:703-704.
47. Miyashita T., Kitada S., Krajewski S., Horne W.A., Delia D., Reed J.C. Overexpression of the Bcl-2 protein increases the half-life of p21Bax. J. Biol. Chem. 1995, 270:26049-26052.
48. Morrish P.K., Sawle G.V., Brooks D.J. Regional changes in [18F]dopa metabolism in the striatum in Parkinson's disease. Brain 1996, 119(Pt 6):2097-2103.
49. Mosharov E.V., Larsen K.E., Kanter E., Phillips K.A., Wilson K., Schmitz Y., et al. Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons. Neuron 2009, 62:218-229.
50. Nacher J., Crespo C., McEwen B.S. Doublecortin expression in the adult rat telencephalon. Eur. J. Neurosci. 2001, 14:629-644.
51. Obeso J.A., Rodriguez-Oroz M.C., Goetz C.G., Marin C., Kordower J.H., Rodriguez M., et al. Missing pieces in the Parkinson's disease puzzle. Nat. Med. 2010, 16:653-661.
52. O'Callaghan J.P. Quantification of glial fibrillary acidic protein: comparison of slot-immunobinding assays with a novel sandwich ELISA. Neurotoxicol. Teratol. 1991, 13:275-281.
53. Oh Y.J., Swarzenski B.C., O'Malley K.L. Overexpression of Bcl-2 in a murine dopaminergic neuronal cell line leads to neurite outgrowth. Neurosci. Lett. 1996, 202:161-164.
54. Ostby Y., Tamnes C.K., Fjell A.M., Westlye L.T., Due-Tonnessen P., Walhovd K.B. Heterogeneity in subcortical brain development: a structural magnetic resonance imaging study of brain maturation from 8 to 30years. J. Neurosci. 2009, 29:11772-11782.
55. Popa-Wagner A., Buga A.M., Kokaia Z. Perturbed cellular response to brain injury during aging. Ageing Res. Rev. 2009, doi:10.1016/j.arr.2009.10.008.
56. Probst-Cousin S., Rickert C.H., Schmid K.W., Gullotta F. Cell death mechanisms in multiple system atrophy. J. Neuropathol. Exp. Neurol. 1998, 57:814-821.
57. Quinn C.C., Gray G.E., Hockfield S. A family of proteins implicated in axon guidance and outgrowth. J. Neurobiol. 1999, 41:158-164.
58. Quinn C.C., Chen E., Kinjo T.G., Kelly G., Bell A.W., Elliott R.C., et al. TUC-4b, a novel TUC family variant, regulates neurite outgrowth and associates with vesicles in the growth cone. J. Neurosci. 2003, 23:2815-2823.
59. Riley H.A. An Atlas of the Basal Ganglia, Brain Stem and Spinal Cord 1943, Williams and Wilkins Co, Baltimore, MD.
60. Rosslenbroich V., Dai L., Franken S., Gehrke M., Junghans U., Gieselmann V., et al. Subcellular localization of collapsin response mediator proteins to lipid rafts. Biochem. Biophys. Res. Commun. 2003, 305:392-399.
61. Rougon G., Dubois C., Buckley N., Magnani J.L., Zollinger W. A monoclonal antibody against meningococcus group B polysaccharides distinguishes embryonic from adult N-CAM. J. Cell Biol. 1986, 103:2429-2437.
62. Rutishauser U. Polysialic acid in the plasticity of the developing and adult vertebrate nervous system. Nat. Rev. Neurosci. 2008, 9:26-35.
63. Silver J. Much Ado about Nogo. Neuron 2010, 66:619-621.
64. Song D.D., Haber S.N. Striatal responses to partial dopaminergic lesion: evidence for compensatory sprouting. J. Neurosci. 2000, 20:5102-5114.
65. Sowell E.R., Peterson B.S., Thompson P.M., Welcome S.E., Henkenius A.L., Toga A.W. Mapping cortical change across the human life span. Nat. Neurosci. 2003, 6:309-315.
66. Sowell E.R., Peterson B.S., Kan E., Woods R.P., Yoshii J., Bansal R., et al. Sex differences in cortical thickness mapped in 176 healthy individuals between 7 and 87years of age. Cereb. Cortex 2007, 17:1550-1560.
67. Styren S.D., Civin W.H., Rogers J. Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain. Exp. Neurol. 1990, 110:93-104.
68. Szele F.G., Dowling J.J., Gonzales C., Theveniau M., Rougon G., Chesselet M.F. Pattern of expression of highly polysialylated neural cell adhesion molecule in the developing and adult rat striatum. Neuroscience 1994, 60:133-144.
69. Szpara M.L., Vranizan K., Tai Y.C., Goodman C.S., Speed T.P., Ngai J. Analysis of gene expression during neurite outgrowth and regeneration. BMC Neurosci. 2007, 8:100.
70. Tint I., Jean D., Baas P.W., Black M.M. Doublecortin associates with microtubules preferentially in regions of the axon displaying actin-rich protrusive structures. J. Neurosci. 2009, 29:10995-11010.
71. Tong J., Hornykiewicz O., Kish S.J. Identification of a noradrenaline-rich subdivision of the human nucleus accumbens. J. Neurochem. 2006, 96:349-354.
72. Tong J., Hornykiewicz O., Kish S.J. Inverse relationship between brain noradrenaline level and dopamine loss in Parkinson disease: a possible neuroprotective role for noradrenaline. Arch. Neurol. 2006, 63:1724-1728.
73. Tong J., Hornykiewicz O., Furukawa Y., Kish S.J. Marked dissociation between high noradrenaline versus low noradrenaline transporter levels in human nucleus accumbens. J. Neurochem. 2007, 102:1691-1702.
74. Tong J., Wong H., Guttman M., Ang L.C., Forno L.S., Shimadzu M., et al. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation. Brain 2010, 133:172-188.
75. Uhl G.R., Walther D., Mash D., Faucheux B., Javoy-Agid F. Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons. Ann. Neurol. 1994, 35:494-498.
76. von Bohlen Und Halbach O. Immunohistological markers for staging neurogenesis in adult hippocampus. Cell Tissue Res. 2007, 329:409-420.
77. Walhovd K.B., Westlye L.T., Amlien I., Espeseth T., Reinvang I., Raz N., et al. Consistent neuroanatomical age-related volume differences across multiple samples. Neurobiol. Aging. 2009, doi:10.1016/j.neurobiolaging.2009.05.013.
78. Wang Q., Xu X., Zhang M. Normal aging in the basal ganglia evaluated by eigenvalues of diffusion tensor imaging. AJNR Am. J. Neuroradiol. 2010, 31:516-520.
79. Yamada T., McGeer P.L., Baimbridge K.G., McGeer E.G. Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K. Brain Res. 1990, 526:303-307.
80. Yang H.K., Sundholm-Peters N.L., Goings G.E., Walker A.S., Hyland K., Szele F.G. Distribution of doublecortin expressing cells near the lateral ventricles in the adult mouse brain. J. Neurosci. Res. 2004, 76:282-295.
81. Zhang K.Z., Westberg J.A., Holtta E., Andersson L.C. BCL2 regulates neural differentiation. Proc. Natl Acad. Sci. USA 1996, 93:4504-4508.